Kwon et al. [6] reported that PKM2 affected gastric cancer cell survival by regulating Bcl-xL at the transcriptional level, elucidating a potential explanation as to why high levels of PKM2 relate to an unfavorable clinical outcome. This evidence concerns the gene PKM and gastric cancer.